Terms: = Brain cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Treatment
1071 results:
1. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Illini O; Saalfeld FC; Christopoulos P; Duruisseaux M; Vikström A; Peled N; Demedts I; Dudnik E; Eisert A; Hashemi SMS; Janzic U; Kian W; Mohorcic K; Mohammed S; Silvoniemi M; Rothschild SI; Schulz C; Wesseler C; Addeo A; Armster K; Itchins M; Ivanović M; Kauffmann-Guerrero D; Koivunen J; Kuon J; Pavlakis N; Piet B; Sebastian M; Velthaus-Rusik JL; Wannesson L; Wiesweg M; Wurm R; Albers-Leischner C; Aust DE; Janning M; Fabikan H; Herold S; Klimova A; Loges S; Sharapova Y; Schütz M; Weinlinger C; Valipour A; Overbeck TR; Griesinger F; Jakopovic M; Hochmair MJ; Wermke M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612799
[TBL] [Abstract] [Full Text] [Related]
2. Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the met pathway in glioblastoma cells.
Chen MS; Chong ZY; Huang C; Huang HC; Su PH; Chen JC
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38606513
[TBL] [Abstract] [Full Text] [Related]
3. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
[TBL] [Abstract] [Full Text] [Related]
4. brain-derived neurotrophic factor Val66met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.
Rodrigues NB; Chen-Li D; Di Vincenzo JD; Juneja A; Pinder BD; McIntyre RS; Rosenblat JD
J Psychopharmacol; 2024 Apr; 38(4):375-381. PubMed ID: 38477185
[TBL] [Abstract] [Full Text] [Related]
5. Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer.
Xu K; Wang H; Zou YX; Zhang HH; Wang YN; Ren XR; Wang HQ; Xu YH; Li JJ; Tang H; He C; Wei S; Tian T; Li LL; Zhou H; Xu LJ; Fang JW; Guo C; Yang JX; Zhou YY; Zhang ZH; Pan YY
Clin Transl Med; 2024 Mar; 14(3):e1605. PubMed ID: 38445456
[TBL] [Abstract] [Full Text] [Related]
6. Serum sodium level fluctuations following the resection of childhood-onset craniopharyngioma.
Miao Y; Fan K; Peng X; Li S; Chen J; Wei Y; Deng Y; Zhao C; Wu Q; Ge M; Gong J; Wu D
Brain Behav; 2024 Mar; 14(3):e3430. PubMed ID: 38433103
[TBL] [Abstract] [Full Text] [Related]
7. Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [
Shahzadi I; Seidlitz A; Beuthien-Baumann B; Zwanenburg A; Platzek I; Kotzerke J; Baumann M; Krause M; Troost EGC; Löck S
Sci Rep; 2024 Feb; 14(1):4576. PubMed ID: 38403632
[TBL] [Abstract] [Full Text] [Related]
8. Long-term experience with tepotinib in Japanese patients with met exon 14 skipping NSCLC from the Phase II VISION study.
Morise M; Kato T; Matsumoto S; Inoue T; Sakamoto T; Tokito T; Atagi S; Kozuki T; Takeoka H; Chikamori K; Shinagawa N; Tanaka H; Horii E; Adrian S; Bruns R; Johne A; Paik PK; Sakai H
Cancer Sci; 2024 Apr; 115(4):1296-1305. PubMed ID: 38402853
[TBL] [Abstract] [Full Text] [Related]
9. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
Odia Y; Hall MD; Cloughesy TF; Wen PY; Arrillaga-Romany I; Daghistani D; Mehta MP; Tarapore RS; Ramage SC; Allen JE
Neuro Oncol; 2024 May; 26(Supplement_2):S165-S172. PubMed ID: 38386699
[TBL] [Abstract] [Full Text] [Related]
10. Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor
Kaneko K; Nagao M; Ueda K; Yamamoto A; Sakai S
Ann Nucl Med; 2024 Apr; 38(4):278-287. PubMed ID: 38386272
[TBL] [Abstract] [Full Text] [Related]
11. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
[TBL] [Abstract] [Full Text] [Related]
12. methyl-
Niitsu H; Fukumitsu N; Tanaka K; Mizumoto M; Nakai K; Matsuda M; Ishikawa E; Hatano K; Hashimoto T; Kamizawa S; Sakurai H
Ann Nucl Med; 2024 Apr; 38(4):305-314. PubMed ID: 38356008
[TBL] [Abstract] [Full Text] [Related]
13. Effects of the Cortisol Milieu on Tumor-Infiltrating Immune Cells in Corticotroph Tumors.
Kanzawa M; Shichi H; Kanie K; Yamamoto M; Yamamoto N; Tsujimoto Y; Bando H; Iguchi G; Kitano S; Inoshita N; Yamada S; Ogawa W; Itoh T; Fukuoka H
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38340329
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
Fairchild A; Salama JK; Godfrey D; Wiggins WF; Ackerson BG; Oyekunle T; Niedzwiecki D; Fecci PE; Kirkpatrick JP; Floyd SR
J Neurooncol; 2024 Mar; 167(1):219-227. PubMed ID: 38340295
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant
Al-Ghabkari A; Huang B; Park M
Cells; 2024 Jan; 13(3):. PubMed ID: 38334610
[TBL] [Abstract] [Full Text] [Related]
16. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
[TBL] [Abstract] [Full Text] [Related]
17. Clinical application of combination [
Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
[TBL] [Abstract] [Full Text] [Related]
18. The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas.
Bono BC; Ninatti G; Riva M; Raspagliesi L; Barbieri EM; Navarria P; Clerici E; Politi LS; Simonelli M; Rodari M; Sollini M; Chiti A; Pessina F
Neurosurg Focus; 2024 Feb; 56(2):E6. PubMed ID: 38301247
[TBL] [Abstract] [Full Text] [Related]
19. Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Sia TY; Wan V; Finlan M; Zhou QC; Iasonos A; Zivanovic O; Sonoda Y; Chi DS; Long Roche K; Jewell E; Tew WP; O'Cearbhaill RE; Cohen S; Makker V; Liu YL; Friedman CF; Kyi C; Zamarin D; Gardner G
Int J Gynecol Cancer; 2024 Apr; 34(4):594-601. PubMed ID: 38296517
[TBL] [Abstract] [Full Text] [Related]
20. The use of MR perfusion parameters in differentiation between glioblastoma recurrence and radiation necrosis.
Bobek-Billewicz B; Heinze S; Awramienko-Wloczek A; Majchrzak K; Nowicka E; Hebda A
Folia Neuropathol; 2023; 61(4):371-378. PubMed ID: 38282486
[TBL] [Abstract] [Full Text] [Related]
[Next]
